How GDPR Will Transform The Disclosure Landscape
King & Spalding
Maite Vazquez Calo
Independent member of the Board of Directors
Cooperative Group Cajamar
Practice Leader Life Science
Takeaway From This Webinar:
- Differences between the EU Transparency Directive and GDPR
- The ‘right to erasure’ and implications for publishing spend data
- The ‘right to forget’ and its relevant application for pharma companies in EU
- Dos and Don’ts of disclosure when preparing for GDPR
Following the promulgation of GDPR in May 2018, the role of Transparency and Compliance professionals will gain more complexity. This webinar is an attempt to share findings and best practices related to pharma spend disclosure in the EU, to resolve some of that complexity, and bring more homogeneity to the data publication process across the region.
Who Should Attend?
Senior and mid-level Transparency, Corporate Compliance and Legal Professionals from the pharmaceutical manufacturing industry in Europe.